Rectal lymph node metastasis in recurrent ovarian carcinoma: Essential role of 18F-FDG PET/CT in treatment planning

4Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Although uncommon, ovarian cancer cells may spread to the rectal lymph nodes. However, few reports have described how to detect and treat such metastases. We report a case of a 59-year-old woman with mesorectal and pararectal lymph node metastases in recurrent ovarian carcinoma, detected conclusively using 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT), and treated by low anterior resection with total mesorectal excision aiming for macroscopic complete resection. The treatment goals for the patient were gradually changed from curative to palliative chemotherapy; she survived for 45 months without rectal obstruction after secondary debulking surgery, and was followed up until autopsy. Thus, 18F-FDG PET/CT may be valuable for detecting rectal lymph node metastasis and can play an essential role in planning treatment for recurrent ovarian carcinoma. © 2013 Kumagai et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Kumagai, K., Okamura, T., Toyoda, M., Senzaki, H., Watanabe, C., & Ohmichi, M. (2013). Rectal lymph node metastasis in recurrent ovarian carcinoma: Essential role of 18F-FDG PET/CT in treatment planning. World Journal of Surgical Oncology, 11. https://doi.org/10.1186/1477-7819-11-184

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free